Determination of the Prevalence of Mycoplasma genitalium in Patients Receiving Diagnostic or Surveillance Testing for Gonorrhea and Chlamydia.
-
- STATUS
- Not Recruiting
Summary
We propose to determine the prevalence of M. genitalium in our patient population by analysis of remnant urogenital tract specimens submitted to the Division of Molecular Pathology at the Indiana University Health Pathology Laboratory (IUHPL) for standard-of-care gonococcal and chlamydial testing. To do so, we will test 1,500 remnant clinical samples, including urine and other urogenital tract specimen types, submitted in Aptima? transport solution (Hologic, Inc., Marlborough, MA), by the Aptima? Mycoplasma genitalium Assay on the fully automated Panther? (Hologic) system.
Description
We propose to determine the prevalence of M. genitalium in our patient population by analysis of remnant urogenital tract specimens submitted to the Division of Molecular Pathology at the Indiana University Health Pathology Laboratory (IUHPL) for standard-of-care gonococcal and chlamydial testing. To do so, we will test 1,500 remnant clinical samples, including urine and other urogenital tract specimen types, submitted in Aptima? transport solution (Hologic, Inc., Marlborough, MA), by the Aptima? Mycoplasma genitalium Assay on the fully automated Panther? (Hologic) system.
Details
| Condition | gonorrhea,chlamydia |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX8372 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.